Generic Injectables Market Research Report, by Product Type (Monoclonal antibodies, Cytokines, Insulin, Vaccines), Container (Vials, Ampoules, Premix, Prefilled syringes), Application (Oncology, Anaesthesia, Anti-infectives, Cardiovascular), Distribution Channel (Hospital pharmacy, Retail pharmacy, Drug stores, Online stores) - Industry Forecast Till 2032

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Overview

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

Chapter 6. Global Generic injectables Market, by Product Type

6.1 Overview

6.2 Monoclonal antibodies

6.3 Cytokines

6.4 Insulin

6.5 Vaccines

6.6 Others

Chapter 7. Global Generic injectables Market, by Container

7.1 Overview

7.2 Vials

7.3 Ampoules

7.4 Premix

7.5 Prefilled syringes

Chapter 8. Global Generic injectables Market, by Application

8.1 Overview

8.2 Oncology

8.3 Anaesthesia

8.4 Anti-infectives

8.5 Parenteral nutrition

8.6 Cardiovascular

8.7 Others

Chapter 9. Global Generic injectables Market, by Distribution Channel

9.1 Overview

9.2 Hospital pharmacy

9.3 Retail pharmacy

9.4 Drug stores

9.5 Online prescription stores

9.6 Others

Chapter 10. Global Generic injectables Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 Latin America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

Chapter 12. Company Profiles

12.1 Novartis AG (Sandoz International GmbH)

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 Baxter

12.3 Fresenius SE & Co. KGaA

12.4 Mylan N.V.

12.5 Teva Pharmaceutical Industries Ltd.

12.6 Hikma Pharmaceuticals plc

12.7 Sanofi

12.8 Biocon

12.9 Dr. Reddy’s Laboratories

12.10 Aurobindo Pharma

12.11 Zydus Cadila

12.12 GlaxoSmithKline plc

12.12 AstraZeneca plc.

12.14 Others

Chapter 13 Appendix

LIST OF TABLES

TABLE 1 GLOBAL GENERIC INJECTABLES MARKET SYNOPSIS, 2022-2030

TABLE 2 GLOBAL GENERIC INJECTABLES MARKET ESTIMATES AND FORECAST, 2022-2030 (USD MILLION)

TABLE 3 GLOBAL GENERIC INJECTABLES MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION)

TABLE 4 GLOBAL GENERIC INJECTABLES MARKET, BY CONTAINER, 2022-2030 (USD MILLION)

TABLE 5 GLOBAL GENERIC INJECTABLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)

TABLE 6 GLOBAL GENERIC INJECTABLES MARKET, BY DISTRIBUTION CHANNEL, 2022-2030 (USD MILLION)

TABLE 7 GLOBAL GENERIC INJECTABLES MARKET, BY REGION, 2022-2030(USD MILLION)

TABLE 8 NORTH AMERICA: GENERIC INJECTABLES MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION)

TABLE 9 NORTH AMERICA: GENERIC INJECTABLES MARKET, BY CONTAINER, 2022-2030 (USD MILLION)

TABLE 10 NORTH AMERICA: GENERIC INJECTABLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)

TABLE 11 NORTH AMERICA: GENERIC INJECTABLES MARKET, BY DISTRIBUTION CHANNEL, 2022-2030 (USD MILLION)

TABLE 12 NORTH AMERICA: GENERIC INJECTABLES MARKET, BY REGION, 2022-2030 (USD MILLION)

TABLE 13 US: GENERIC INJECTABLES MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION)

TABLE 14 US: GENERIC INJECTABLES MARKET, BY CONTAINER, 2022-2030 (USD MILLION)

TABLE 15 US: GENERIC INJECTABLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)

TABLE 16 US: GENERIC INJECTABLES MARKET, BY DISTRIBUTION CHANNEL, 2022-2030 (USD MILLION)

TABLE 17 US: GENERIC INJECTABLES MARKET, BY REGION, 2022-2030 (USD MILLION)

TABLE 18 CANADA: GENERIC INJECTABLES MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION)

TABLE 19 CANADA: GENERIC INJECTABLES MARKET, BY CONTAINER, 2022-2030 (USD MILLION)

TABLE 20 CANADA: GENERIC INJECTABLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)

TABLE 21 CANADA: GENERIC INJECTABLES MARKET, BY DISTRIBUTION CHANNEL, 2022-2030 (USD MILLION)

TABLE 22 CANADA: GENERIC INJECTABLES MARKET, BY REGION, 2022-2030 (USD MILLION)

TABLE 23 SOUTH AMERICA: GENERIC INJECTABLES MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION)

TABLE 24 SOUTH AMERICA: GENERIC INJECTABLES MARKET, BY CONTAINER, 2022-2030 (USD MILLION)

TABLE 25 SOUTH AMERICA: GENERIC INJECTABLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)

TABLE 26 SOUTH AMERICA: GENERIC INJECTABLES MARKET, BY DISTRIBUTION CHANNEL, 2022-2030 (USD MILLION)

TABLE 27 SOUTH AMERICA: GENERIC INJECTABLES MARKET, BY REGION, 2022-2030 (USD MILLION)

TABLE 28 EUROPE: GENERIC INJECTABLES MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION)

TABLE 29 EUROPE: GENERIC INJECTABLES MARKET, BY CONTAINER, 2022-2030 (USD MILLION)

TABLE 30 EUROPE: GENERIC INJECTABLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)

TABLE 31 EUROPE: GENERIC INJECTABLES MARKET, BY DISTRIBUTION CHANNEL, 2022-2030 (USD MILLION)

TABLE 32 EUROPE: GENERIC INJECTABLES MARKET, BY REGION, 2022-2030 (USD MILLION)

TABLE 33 WESTERN EUROPE: GENERIC INJECTABLES MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION)

TABLE 34 WESTERN EUROPE GENERIC INJECTABLES MARKET, BY CONTAINER, 2022-2030 (USD MILLION)

TABLE 35 WESTERN EUROPE: GENERIC INJECTABLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)

TABLE 36 WESTERN EUROPE: GENERIC INJECTABLES MARKET, BY DISTRIBUTION CHANNEL, 2022-2030 (USD MILLION)

TABLE 37 WESTERN EUROPE: GENERIC INJECTABLES MARKET, BY REGION, 2022-2030 (USD MILLION)

TABLE 38 EASTERN EUROPE: GENERIC INJECTABLES MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION)

TABLE 39 EASTERN EUROPE GENERIC INJECTABLES MARKET, BY CONTAINER, 2022-2030 (USD MILLION)

TABLE 40 EASTERN EUROPE: GENERIC INJECTABLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)

TABLE 41 EASTERN EUROPE: GENERIC INJECTABLES MARKET, BY DISTRIBUTION CHANNEL, 2022-2030 (USD MILLION)

TABLE 42 EASTERN EUROPE: GENERIC INJECTABLES MARKET, BY REGION, 2022-2030 (USD MILLION)

TABLE 43 ASIA-PACIFIC: GENERIC INJECTABLES MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION)

TABLE 44 ASIA-PACIFIC GENERIC INJECTABLES MARKET, BY CONTAINER, 2022-2030 (USD MILLION)

TABLE 45 ASIA-PACIFIC: GENERIC INJECTABLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)

TABLE 46 ASIA-PACIFIC: GENERIC INJECTABLES MARKET, BY DISTRIBUTION CHANNEL, 2022-2030 (USD MILLION)

TABLE 47 ASIA-PACIFIC: GENERIC INJECTABLES MARKET, BY REGION, 2022-2030 (USD MILLION)

TABLE 48 MIDDLE EAST & AFRICA: GENERIC INJECTABLES MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION)

TABLE 49 MIDDLE EAST & AFRICA GENERIC INJECTABLES MARKET, BY CONTAINER, 2022-2030 (USD MILLION)

TABLE 50 MIDDLE EAST & AFRICA: GENERIC INJECTABLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)

TABLE 51 MIDDLE EAST & AFRICA: GENERIC INJECTABLES MARKET, BY DISTRIBUTION CHANNEL, 2022-2030 (USD MILLION)

TABLE 52 MIDDLE EAST & AFRICA: GENERIC INJECTABLES MARKET, BY REGION, 2022-2030 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 SEGMENTATION FOR GLOBAL GENERIC INJECTABLES MARKET

FIGURE 3 MARKET DYNAMICS FOR GLOBAL GENERIC INJECTABLES MARKET

FIGURE 4 GLOBAL GENERIC INJECTABLES MARKET SHARE, BY PRODUCT TYPE, 2020 (%)

FIGURE 5 GLOBAL GENERIC INJECTABLES MARKET, BY CONTAINER, 2020 (%)

FIGURE 6 GLOBAL GENERIC INJECTABLES MARKET SHARE, BY APPLICATION, 2020 (%)

FIGURE 7 GLOBAL GENERIC INJECTABLES MARKET SHARE, BY DISTRIBUTION CHANNEL, 2020 (%)

FIGURE 8 GLOBAL GENERIC INJECTABLES MARKET SHARE, BY REGION, 2020 (%)

FIGURE 9 NORTH AMERICA: GENERIC INJECTABLES MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 10 EUROPE: GENERIC INJECTABLES MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 11 ASIA-PACIFIC: GENERIC INJECTABLES MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 12 MIDDLE EAST & AFRICA: GENERIC INJECTABLES MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 13 GLOBAL GENERIC INJECTABLES MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 14 NOVARTIS AG: KEY FINANCIALS

FIGURE 15 NOVARTIS AG: SEGMENTAL REVENUE

FIGURE 16 NOVARTIS AG: GEOGRAPHICAL REVENUE

FIGURE 17 BAXTER: KEY FINANCIALS

FIGURE 18 BAXTER: SEGMENTAL REVENUE

FIGURE 19 BAXTER: GEOGRAPHICAL REVENUE

FIGURE 20 FRESENIUS SE & CO. KGAA: KEY FINANCIALS

FIGURE 21 FRESENIUS SE & CO. KGAA: SEGMENTAL REVENUE

FIGURE 22 FRESENIUS SE & CO. KGAA: GEOGRAPHICAL REVENUE

FIGURE 23 MYLAN N.V.: KEY FINANCIALS

FIGURE 24 MYLAN N.V.: SEGMENTAL REVENUE

FIGURE 25 MYLAN N.V.: GEOGRAPHICAL REVENUE

FIGURE 26 TEVA PHARMACEUTICAL INDUSTRIES LTD: KEY FINANCIALS

FIGURE 27 TEVA PHARMACEUTICAL INDUSTRIES LTD: SEGMENTAL REVENUE

FIGURE 28 TEVA PHARMACEUTICAL INDUSTRIES LTD: GEOGRAPHICAL REVENUE

FIGURE 29 HIKMA PHARMACEUTICALS PLC: KEY FINANCIALS

FIGURE 30 HIKMA PHARMACEUTICALS PLC: SEGMENTAL REVENUE

FIGURE 31 HIKMA PHARMACEUTICALS PLC: GEOGRAPHICAL REVENUE

FIGURE 32 SANOFI: KEY FINANCIALS

FIGURE 33 SANOFI: SEGMENTAL REVENUE

FIGURE 34 SANOFI: GEOGRAPHICAL REVENUE

FIGURE 35 BIOCON: KEY FINANCIALS

FIGURE 36 BIOCON: SEGMENTAL REVENUE

FIGURE 37 BIOCON: GEOGRAPHICAL REVENUE

FIGURE 38 DR. REDDY’S LABORATORIES: KEY FINANCIALS

FIGURE 39 DR. REDDY’S LABORATORIES: SEGMENTAL REVENUE

FIGURE 40 DR. REDDY’S LABORATORIES: GEOGRAPHICAL REVENUE